Respiratory News and Research

RSS

Obese kids exposed to high levels of air pollutants are nearly 3 times as likely to have asthma

Obese children exposed to high levels of air pollutants were nearly three times as likely to have asthma, compared with non-obese children and lower levels of pollution exposure, report researchers at Columbia University Medical Center (CUMC).

23 Jan 2014

UC researchers receive more than $1M grant to study complex traumatic injuries of warfare

Trauma and critical care researchers at the University of Cincinnati (UC) have received more than $1 million from the United States Air Force in a recent set of grant awards to study how air medical evacuation affects patients, medical professionals and medical equipment.

22 Jan 2014

New study raises hope to successfully fight chytridiomycosis

An international team of researchers has made important progress in understanding the distribution of the deadly amphibian chytrid pathogen. In some regions, the deadly impact of the pathogen appears to be hampered by small predators, naturally occurring in freshwater bodies. These micropredators may efficiently reduce the number of free-swimming infectious stages (zoospores) by consuming them. This natural behavior will reduce the infection pressure on potential amphibian hosts and a goes a long way towards explaining the occurrence of chytridiomycosis, at least in temporal climatic regions.

21 Jan 2014

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, announced that reported diluted earnings per share equaled $0.07 in the third quarter of fiscal 2014, compared to a reported loss per share of ($0.58) in the third quarter of fiscal 2013. The third quarter of fiscal 2014 included a $45 million charge ($28.2 million net of tax) related to Project Rejuvenate.

21 Jan 2014

Alexion's Soliris gets FDA orphan drug designation for DGF prevention in renal transplant patients

Alexion Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted an orphan drug designation to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of delayed graft function in renal transplant patients.

21 Jan 2014

First antigen test for human bocavirus type 1 now available on ArcDia's mariPOC test platform

ArcDia Ltd. ArcDia International Ltd today announced that the first antigen test for human bocavirus type 1 is now commercially available on ArcDia's mariPOC test platform.

21 Jan 2014

TSRI scientists use new technique to discover two antibodies that protect human cells from cold virus

Scientists at The Scripps Research Institute (TSRI) have demonstrated the power of a new drug discovery technique, which allows them to find-relatively quickly and cheaply-antibodies that have a desired effect on cells. The TSRI scientists used the technique to discover two antibodies that protect human cells from a cold virus.

20 Jan 2014

Hospitals with more experience caring for patients with severe sepsis achieve better outcomes

A recent study led by Boston University School of Medicine (BUSM) shows that "practice may make perfect" when it comes to caring for patients with severe sepsis.

20 Jan 2014

$Japanese MHLW approves ADCETRIS for relapsed or refractory CD30-positive HL and ALCL$

Japanese MHLW approves ADCETRIS for relapsed or refractory CD30-positive HL and ALCL

Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval of ADCETRIS (brentuximab vedotin) from the Japanese Ministry of Health, Labour and Welfare for the treatment of patients with CD30-positive relapsed or refractory Hodgkin lymphoma and anaplastic large cell lymphoma.

18 Jan 2014

Continued use of statins may help prevent delirium in critically ill patients

Continued use of statins may help prevent delirium in critically ill patients who received statins before hospital admission, according to a new study of 470 intensive care patients in the UK.

17 Jan 2014

American Diabetes Association receives $5M grant for Pathway to Stop Diabetes program

AstraZeneca and Bristol-Myers Squibb Company today announced that the companies' U.S. Diabetes Alliance is providing a three-year grant to the American Diabetes Association's Pathway to Stop Diabetes program. The innovative research initiative provides resources and support for a new generation of diabetes researchers and is designed to generate exciting discoveries through excellence, innovation, collaboration and radical thinking.

16 Jan 2014

RoundTable Healthcare Partners sells Aqua Pharmaceuticals Holdings for $402.6M to Almirall

RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has completed the sale of Aqua Pharmaceuticals Holdings, Inc. to Almirall S.A. for up to $402.6 million in cash

16 Jan 2014

Scientists develop new nasal vaccine that proves effective against whooping cough

Scientists involved in the EU-funded project ChildInnovac are about to publish in the online journal Plos One the results of their first clinical trial of a new nasal vaccine.

16 Jan 2014

FDA approves Farxiga tablets to improve glycemic control in adults with type 2 diabetes mellitus

AstraZeneca and Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration approved Farxiga™ [far-SEE-ga] (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

13 Jan 2014

Cord blood vitamin D linked to pediatric RTI risk

South Korean researchers say that encouraging pregnant women to spend more time outdoors or to increase their vitamin D supplementation may reduce the number of respiratory tract infections in their infants.

13 Jan 2014

Study indicates some groups have specific genetic make-up that prevents from fighting off influenza

Research indicated that some Indigenous people such as in Alaska and Australia displayed limited immunity response to the effects of influenza.

13 Jan 2014

Meridian's TRU FLU assay gets FDA clearance for analytical sensitivity claim for avian Influenza H7N9 strain

Meridian Bioscience, Inc. today announced that the company's TRU FLU assay received FDA clearance for an analytical sensitivity claim for the novel avian Influenza H7N9 strain, A/Anhui/1/2013. TRU FLU is a rapid immunoassay that detects influenza A and influenza B viruses in 15 minutes in human respiratory specimens.

10 Jan 2014

Patient's own bone-marrow stromal cells could treat multi-drug resistant TB

Findings of a preliminary study published in The Lancet Respiratory Medicine suggest that a patient’s own bone-marrow stromal (stem) cells could be used to treat multidrug-resistant (MDR) and extensively-drug (XDR) tuberculosis.

10 Jan 2014

AOM associated with significant increases in direct costs incurred by consumers, health care system

Acute otitis media, or ear infection, is the most common ailment among kids of preschool age and younger in the U.S., primarily because these children have immature middle-ear drainage systems, higher exposure to respiratory illnesses and undeveloped immune systems.

10 Jan 2014

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure

Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G-protein coupled receptor biased ligands, announced today initiation of dosing in BLAST-AHF, the Company's randomized, multi-center Phase 2b trial of TRV027 in patients with acute heart failure.

9 Jan 2014

Respiratory News and Research

Obese kids exposed to high levels of air pollutants are nearly 3 times as likely to have asthma

UC researchers receive more than $1M grant to study complex traumatic injuries of warfare

New study raises hope to successfully fight chytridiomycosis

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

Alexion's Soliris gets FDA orphan drug designation for DGF prevention in renal transplant patients

First antigen test for human bocavirus type 1 now available on ArcDia's mariPOC test platform

TSRI scientists use new technique to discover two antibodies that protect human cells from cold virus

Hospitals with more experience caring for patients with severe sepsis achieve better outcomes

Japanese MHLW approves ADCETRIS for relapsed or refractory CD30-positive HL and ALCL

Continued use of statins may help prevent delirium in critically ill patients

American Diabetes Association receives $5M grant for Pathway to Stop Diabetes program

RoundTable Healthcare Partners sells Aqua Pharmaceuticals Holdings for $402.6M to Almirall

Scientists develop new nasal vaccine that proves effective against whooping cough

FDA approves Farxiga tablets to improve glycemic control in adults with type 2 diabetes mellitus

Cord blood vitamin D linked to pediatric RTI risk

Study indicates some groups have specific genetic make-up that prevents from fighting off influenza

Meridian's TRU FLU assay gets FDA clearance for analytical sensitivity claim for avian Influenza H7N9 strain

Patient's own bone-marrow stromal cells could treat multi-drug resistant TB

AOM associated with significant increases in direct costs incurred by consumers, health care system

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News